These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 31966650)
1. Long noncoding RNA CCAT2 promotes proliferation and metastasis in non-small cell lung cancer through the Wnt pathway. Li J; Liu Y; Li P; Guo Y; Liu Y; Ren Y Int J Clin Exp Pathol; 2017; 10(7):7983-7990. PubMed ID: 31966650 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt/β-catenin signaling pathway. Zhao C; Qiao C; Zong L; Chen Y Oncol Lett; 2018 Oct; 16(4):4600-4606. PubMed ID: 30214594 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway. He P; Xiong G; Guo W; Jiang G; Li Y; Li H Oncol Lett; 2020 Oct; 20(4):97. PubMed ID: 32831916 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway. Wang X; Wang X Oncol Lett; 2019 Aug; 18(2):1745-1754. PubMed ID: 31423241 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma. Huang JL; Liao Y; Qiu MX; Li J; An Y Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells. Wang B; Liu M; Zhuang R; Jiang J; Gao J; Wang H; Chen H; Zhang Z; Kuang Y; Li P Oncol Lett; 2018 Mar; 15(3):3369-3375. PubMed ID: 29435081 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway. Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713 [TBL] [Abstract][Full Text] [Related]
8. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Qiu M; Xu Y; Yang X; Wang J; Hu J; Xu L; Yin R Tumour Biol; 2014 Jun; 35(6):5375-80. PubMed ID: 24504682 [TBL] [Abstract][Full Text] [Related]
9. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway. Ma Y; Hu X; Shang C; Zhong M; Guo Y Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the Yang C; Li F; Zhou W; Huang J J Int Med Res; 2021 May; 49(5):3000605211019938. PubMed ID: 34057837 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Cai Y; He J; Zhang D Onco Targets Ther; 2015; 8():2657-64. PubMed ID: 26442763 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway. Fu X; Li H; Liu C; Hu B; Li T; Wang Y Onco Targets Ther; 2016; 9():3815-27. PubMed ID: 27445486 [TBL] [Abstract][Full Text] [Related]
13. Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway. Wang BD; Jiang J; Liu MM; Zhuang RJ; Wang H; Li PL Int J Clin Exp Pathol; 2017; 10(12):11771-11778. PubMed ID: 31966540 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Huang S; Qing C; Huang Z; Zhu Y Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598 [TBL] [Abstract][Full Text] [Related]
15. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion. Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065 [TBL] [Abstract][Full Text] [Related]
16. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma. Ruan R; Zhao XL Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240 [TBL] [Abstract][Full Text] [Related]
17. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312 [TBL] [Abstract][Full Text] [Related]
18. LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer. Zhao Z; Wang J; Wang S; Chang H; Zhang T; Qu J Biomed Pharmacother; 2017 Mar; 87():692-697. PubMed ID: 28088736 [TBL] [Abstract][Full Text] [Related]
19. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400 [TBL] [Abstract][Full Text] [Related]
20. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]